Researchers conducted genetic testing of various types of fish procured in restaurants, sushi joints, and fish markets in 21 states between 2010 and 2012.
Netflix was an early-adopter of these types of services and ultimately has become a success story for leveraging shared resources at the start of testing a business model before investing in dedicated hardware.
But Bristol-Myers hopes to vastly expand this market by testing Erbitux for numerous additional types of cancer, including tumors of the lung, pancreas and head and neck.